← All companies

Keros Therapeutics

Healthcare & Life Sci

Company overview

Keros Therapeutics is a biopharmaceutical company developing therapies that target disorders related to transforming growth factor-beta (TGF-beta) signaling. It aims to create disease-modifying treatments for patients with unmet medical needs. Its product candidates, KER-050 and KER-065, are in development for neuromuscular and hematology disorders.

Keros Therapeutics has a partnership with Takeda Pharmaceutical Company, a link to a large pharmaceutical partner that can matter for a smaller biotech's funding and stability. Keros Therapeutics is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
Lexington, United States

Filters

Create your account

Create an account to save jobs and track applications.